Asian Farmers to Benefit from New Syngenta–Ascribe Biofungicide Partnership
Syngenta, one of the world’s leading agricultural technology companies, has entered into a landmark development and supply agreement with Ascribe Bioscience to commercialize PHYTALIX®, an innovative biofungicide designed to strengthen crop defenses against a broad range of diseases. The partnership marks a significant step forward in the development and adoption of biological crop protection solutions, particularly for rice farmers across Southeast Asia who are facing mounting challenges from climate change, disease pressure, and evolving pathogen resistance.
Under the agreement, Syngenta will receive exclusive commercial rights to market and distribute PHYTALIX® for rice and several other major crops throughout Southeast Asia. The companies also see potential opportunities to expand the product’s reach into additional markets in the future, reflecting growing global demand for sustainable and effective crop protection technologies.
The collaboration follows four years of extensive evaluation and field validation conducted by Syngenta. During this period, PHYTALIX® consistently demonstrated strong performance across a variety of agricultural environments and disease management programs. Trial results showed the product’s ability to significantly enhance crop resistance against fungal, bacterial, and viral pathogens while contributing to stable and meaningful yield improvements, particularly in rice production systems.
One of the most notable outcomes from the field evaluations was the product’s effectiveness against Bacterial Leaf Blight, one of the most damaging rice diseases in Asia. The disease can severely reduce crop productivity, causing substantial economic losses for farmers. By strengthening plants’ natural defense mechanisms, PHYTALIX® has shown considerable promise as a valuable addition to integrated pest management (IPM) programs aimed at reducing disease pressure while maintaining high productivity.
PHYTALIX® is based on scientific discoveries originally made at the Boyce Thompson Institute at Cornell University. Unlike traditional crop protection products that directly target pathogens, the technology works by mimicking natural plant signaling processes. This approach activates and enhances a plant’s own immune system, enabling crops to better defend themselves against a wide spectrum of disease-causing organisms throughout the growing season.
The technology has demonstrated potential across multiple major agricultural crops, including rice, soybeans, corn, and wheat. By empowering plants to activate their natural defense responses, PHYTALIX® offers a novel mode of action that complements both conventional crop protection products and other biological solutions. This characteristic is particularly important as farmers and agricultural industries seek new approaches to managing disease resistance and reducing dependence on a limited number of chemical control methods.
The partnership comes at a critical time for global rice production. Rice remains the primary food source for nearly half of the world’s population and plays a vital role in food security across Asia. However, rice growers are increasingly challenged by climate-related stresses, shifting weather patterns, emerging plant diseases, and pathogen populations that are developing resistance to existing treatments. These pressures are creating an urgent need for innovative technologies capable of protecting yields while supporting more sustainable farming practices.
PHYTALIX® is expected to fill an important gap between conventional chemical products and biological crop protection tools. The product offers several practical advantages for farmers, including high stability, low application rates, and broad-spectrum disease protection. These features make it suitable for a wide range of farming operations, from smallholder producers to large commercial enterprises.
In addition to its disease management capabilities, the product’s unique biological mechanism supports the growing trend toward integrated crop management systems. Agricultural experts increasingly advocate combining biological and conventional solutions to create more resilient production systems that can address multiple challenges simultaneously. By integrating products such as PHYTALIX® into existing disease management programs, farmers may be able to improve crop health while reducing the risk of resistance development.
Emilhano Lima, Global Head of Seedcare and Biologicals at Syngenta, emphasized the strategic importance of the collaboration and the company’s commitment to accelerating biological innovation in agriculture.
“The collaboration with Ascribe reflects our commitment to bringing farmers differentiated solutions that help them implement more efficient farming strategies and more modern farming approaches through the combined use of conventional and biological products,” Lima said.
He further highlighted the importance of industry partnerships in advancing agricultural innovation.
“Partnering with other innovators in the industry is crucial to accelerate the delivery of biological solutions to the farmers who need them most,” he added.
For Ascribe Bioscience, the agreement represents a major milestone in translating scientific discoveries into practical agricultural solutions. The company has focused on developing technologies that harness natural plant defense systems to improve crop resilience while reducing reliance on traditional chemical interventions.
Dr. Jay Farmer, co-founder and Chief Executive Officer of Ascribe Bioscience, noted that the partnership with Syngenta will help bring the technology to farmers on a much larger scale.
“By partnering with Syngenta in Asia, we’re able to bring this innovation out of the lab and into the hands of farmers who need new, sustainable options to manage crop diseases,” Farmer said. “Syngenta’s partnership represents strong validation of the global potential for PHYTALIX®.”
The companies are now preparing to advance regulatory registration activities and market development efforts across the targeted Asian countries. These activities will include further product testing, regulatory submissions, and engagement with farmers, agricultural advisors, and distribution partners to support future commercialization.
According to the companies, the first commercial launches of PHYTALIX® in Asia are planned for 2029. Once introduced, the product is expected to provide rice growers and other crop producers with a new tool to combat disease pressures while supporting productivity, sustainability, and long-term agricultural resilience.
As biological solutions continue to gain importance within global agriculture, the Syngenta-Ascribe partnership highlights the growing role of innovation in addressing some of the industry’s most pressing challenges. By combining advanced plant science with large-scale commercial expertise, the two companies aim to deliver a next-generation disease management solution capable of helping farmers meet rising food demand while navigating an increasingly complex agricultural landscape.
Source Link:https://www.businesswire.com/
